by qfrsolutions | Apr 15, 2016 | News
Source: Reuters BY OLIVIA ORAN AND CARL O’DONNELL Valeant Pharmaceuticals International Inc (VRX.TO) has brought in investment banks to review its options amid interest from buyout firms and other companies in a number of its businesses, according to people...
by qfrsolutions | Apr 4, 2016 | News
Source: PR Newswire FORT WORTH, Texas, [April 4, 2016] – Galderma, a global leader in medical solutions for skin health, and Mentor Worldwide LLC, a global leader in breast aesthetics and reconstruction, today announced a new nationwide collaboration to partner with...
by qfrsolutions | Mar 30, 2016 | News
Source: The Wall Street Journal By AUSTEN HUFFORD Updated March 30, 2016 11:45 a.m. ET Valeant Pharmaceuticals International Inc. sought some room to maneuver Wednesday, asking its lenders to relax some debt-covenant terms and give it an additional month to file its...
by qfrsolutions | Mar 1, 2016 | News
Source: Anacor Pharmaceuticals, Inc. (ANAC) announced today that data from its Phase 3 pivotal studies of investigational drug crisaborole topical ointment, 2% will be presented at the 74th Annual Meeting of the American Academy of Dermatology in Washington, D.C....
by qfrsolutions | Jan 12, 2016 | News
Source: BioSpace Almirall acquired a minority stake in US based company ThermiGen LLC and plans to close the complete acquisition of ThermiGen by January 31st, 2016. First step towards building a presence in the aesthetics market that helps to further consolidate its...
by qfrsolutions | Jan 8, 2016 | News
Source: Anacor Pharmaceuticals, Inc. (ANAC) announced today that it will present data from the long-term safety study of crisaborole topical ointment, 2% in children and adults with mild-to-moderate atopic dermatitis at the Winter Clinical Dermatology Conference,...
